ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconIcon FacebookIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerPositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Process Industries

Teijin Ltd.

  • 1,829.00 JPY
  • -17.00
  • -0.92%
  • Japan
    Jan 18, 2019
  • Ticker
    TKS(3401)
  • Prev. close
    1,846
  • Market cap (JPY)
    365,423M
  • Market cap (USD)
    3,335.36M
  • Shares
    197.95M

Business Summary

Teijin Ltd. engages in the management of its group companies that are involved in the environment and energy, safety and protection, information and electronics, transportation, and healthcare businesses. It operates through the following segments: Materials, Healthcare, and Others. The Materials segment handles the manufacture and sale of polyester, aramid, and carbon fiber products as well as plastic and resin products from polycarbonate resin and polyester film. The Healthcare segment deals with the manufacture and sale of pharmaceuticals and home medical equipment. It also provides home healthcare services. The Others segment offers information technology services. The company was founded by Seita Kumura on June 17, 1918 and is headquartered in Osaka, Japan.

Financial Highlights

Mar 2018 JPYUSD
Revenue834,985M7,533.76M
Gross Profit258,403M2,331.47M
Operating income69,822M629.97M
Income before tax67,894M612.58M
Net income45,556M411.03M
EBITDA115,477M1,041.90M
Diluted EPS209.611.89
Dividends Per Share600.54
Total Assets986,184M9,273.00M
Total liabilities577,944M5,434.35M
Total equity393,785M3,702.72M
Operating cash flow80,091M722.63M
Currency in JPYCurrency in USD

Historical Data

 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 784,424M 786,171M 790,748M 741,291M 834,985M
Gross Profit 187,189M 210,089M 248,336M 241,105M 258,403M
Operating income 18,078M 39,086M 67,130M 56,512M 69,822M
Income before tax 14,519M -6,927M 45,580M 33,928M 67,894M
Net income 8,356M -8,086M 31,090M 50,133M 45,556M
EBITDA 63,741M 82,116M 106,023M 98,105M 115,477M
Diluted EPS 42.40 -41.15 143.40 231.09 209.61
Dividends Per Share 20 20 35 55 60
Total Assets 768,411M 823,694M 823,429M 964,053M 986,184M
Total liabilities 468,299M 520,059M 509,017M 612,219M 577,944M
Total equity 282,418M 287,919M 300,950M 339,246M 393,785M
Operating cash flow 38,586M 76,030M 80,640M 79,040M 80,091M
 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 7,830.80M 7,156.34M 6,584.94M 6,845.58M 7,533.76M
Gross Profit 1,868.68M 1,912.39M 2,068.01M 2,226.52M 2,331.47M
Operating income 180.47M 355.79M 559.02M 521.87M 629.97M
Income before tax 144.94M -63.05M 379.56M 313.31M 612.58M
Net income 83.41M -73.60M 258.90M 462.96M 411.03M
EBITDA 636.31M 747.48M 882.90M 905.96M 1,041.90M
Diluted EPS 0.42 -0.37 1.19 2.13 1.89
Dividends Per Share 0.19 0.18 0.29 0.50 0.54
Total Assets 7,461.38M 6,868.40M 7,326.20M 8,651.64M 9,273.00M
Total liabilities 4,547.25M 4,336.53M 4,528.82M 5,494.20M 5,434.35M
Total equity 2,742.32M 2,400.82M 2,677.61M 3,044.47M 3,702.72M
Operating cash flow 385.19M 692.08M 671.52M 729.90M 722.63M

Valuation Measures

Mar 2018
PER8.65
ROA4.67%
ROE12.42%
Operating margin8.36%
Profit margin5.45%

Key executives

  • Executive President, CEO & Representative Director: Jun Suzuki
  • CFO, Representative Director & Vice President: Kazuhiro Yamamoto
  • Executive Officer & Manager-IT Business Group: Norihiro Takehara
  • Director & Head-Corporate & Business Strategy: Yoshihisa Sonobe
  • Director & Senior Executive Officer: Hiroshi Uno

Shareholders

  • Asset Management One Co., Ltd. (3.7%)
  • Nippon Life Insurance Co. (3.6%)
  • Nomura Asset Management Co., Ltd. (3.5%)
  • BlackRock Fund Advisors (3.2%)
  • Teijin Ltd. (3.1%)
  • Teijin Employee Stock Ownership Plan (2.4%)
  • The Vanguard Group, Inc. (2.3%)
  • BlackRock Japan Co., Ltd. (1.6%)
  • Dimensional Fund Advisors LP (1.6%)
  • Daiwa Asset Management Co. Ltd. (1.5%)

Contact Details

  • Website:http://www.teijin.co.jp
  • Address: Kasumigaseki Common Gate West Tower, 3-2-1 Kasumigaseki, Tokyo, 100-8585, Japan
  • Phone: +81.3.3506.4529

Related Companies

  • Teijin MedTecHeart Co., Ltd.
  • Radius Health, Inc. /Abaloparatide-SC Asset/
  • Teijin India Pvt Ltd.
  • Teijin Medical Technologies Co., Ltd.
  • Tianjin Zhaohong Metal Product Co. Ltd.
  • Teijin Corporation (Thailand) Ltd.
  • Teijin Aramid France EURL
  • Teijin Aramid Asia Co., Ltd.
  • Nantong Teijin Automotive Fabrics Finishing Co., Ltd.
  • Teijin Medical Devices (Shanghai) Co., Ltd.
  • Teijin Modern Yarn (Nantong) Co., Ltd.
  • Teijin Product Development China Co., Ltd.
  • Teijin Lielsort Korea Co., Ltd.
  • Shanghai Teijin Kasei Trading Co. Ltd.
  • Teijin Hong Kong Ltd.
  • Teijin Polycarbonate China Ltd.
  • Shenzhen Teijin Kasei Trading Co. Ltd.
  • Teijin Kasei (HK) Ltd.
  • Teijin Chemicals Plastic Compounds Shanghai Ltd.
  • Teijin Frontier Co., Ltd.
  • Taiwan Teijin Kasei Co., Ltd.
  • Teijin Holdings USA, Inc.
  • Teijin Pharma USA LLC
  • Teijin Aramid do Brasil Ltda.
  • Teijin Group China Management Ltd.
  • Teijin (China) Investment Co., Ltd.
  • Teijin Trust
  • Tokyo Ramie Spinning Co., Ltd.
  • Inapal Plasticos SA
  • Teijin Aramid BV

Competitors

  • DowDuPont Inc.
  • HUVIS CORPORATION
  • Celanese Corporation
  • Samyang Corporation
  • Formosa Chemicals & Fibre Corporation
  • Wah Hong Industrial Corp.
  • Polyplex (Thailand) Public Co. Ltd.
  • Jindal Poly Films Limited
  • Core Molding Technologies, Inc.
  • Covestro AG
  • UFlex Limited
  • Sinochem International Corporation Class A
  • Fuwei Films (Holdings) Co., Ltd.
  • Green Seal Holding Ltd.
  • Tredegar Corporation
  • vTv Therapeutics, Inc. Class A
  • Samyang Holdings Corporation
Last Updated on 18 Jan, 2019

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends January 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media